Concepedia

Anwesha Dey

AD

31

Publications

3.1K

Citations

24

H-Index

2004

Active since

Affiliations

Molecular Oncology (United States)(Current)

Institute of Molecular and Cell Biology

Gene Therapy Laboratory

Washington University in St. Louis

Howard Hughes Medical Institute

Anwesha Dey is an author at Molecular Oncology (United States) specializing in medicine, cell biology, and molecular biology.

Top concepts

MedicineCell BiologySystems BiologyNatural SciencesMolecular BiologyHealthBiochemistryPharmacologyGene ExpressionOxidative Stress

Publications per year

2004–2025

31

Publications

31

Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation

Anwesha Dey, Dhaya Seshasayee, Rajkumar Noubade et al. · Science · 2012 · 416 citations · Full text

Hematological Malignancy, Cancer Research, Chromatin +12

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo

Omar Abdel‐Wahab, Jie Gao, Mazhar Adli et al. · The Journal of Experimental Medicine · 2013 · 319 citations · Full text

Hematological Malignancy, Asxl1 Results, Human Mds +15

Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling

Cameron L. Noland, Sarah Gierke, Paul D. Schnier et al. · Structure · 2015 · 246 citations · Full text

Hippo Pathway, Systems Biology, Signal Transduction +12

Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury

Jun-Jae Chung, Leonard D. Goldstein, Ying-Jiun J. Chen et al. · Journal of the American Society of Nephrology · 2020 · 179 citations · Full text

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

Thijs J. Hagenbeek, Marc Hafner, Rana Mroue et al. · Nature Cancer · 2023 · 169 citations · Full text

Rows per page

1–5 of 31